C2 Ceramide [3102-57-6]

Referencia HY-101180-5mg

embalaje : 5mg

Marca : MedChemExpress

Solicitar más información

Contact local distributor :


Teléfono : +1 850 650 7790

C2 Ceramide (Ceramide 2) is the main lipid of the stratum corneum and a protein phosphatase 1 (PP1) activator. C2 Ceramide activates PP2A and ceramide-activated protein phosphatase (CAPP). C2 Ceramide induces cells differentiation, autophagy and apoptosis, inhibits mitochondrial respiratory chain complex III. C2 Ceramide is also a skin conditioning agent that protects the epidermal barrier from water loss.

Para uso exclusivo en investigación. No vendemos a pacientes.

C2 Ceramide Estructura química

C2 Ceramide Estructura química

No. CAS : 3102-57-6

This product is a controlled substance and not for sale in your territory.

Based on 1 publication(s) in Google Scholar

Descripciòn

C2 Ceramide (Ceramide 2) is the main lipid of the stratum corneum and a protein phosphatase 1 (PP1) activator. C2 Ceramide activates PP2A and ceramide-activated protein phosphatase (CAPP). C2 Ceramide induces cells differentiation, autophagy and apoptosis, inhibits mitochondrial respiratory chain complex III. C2 Ceramide is also a skin conditioning agent that protects the epidermal barrier from water loss[1][2][3][4][5].

IC50 & Target

Protein phosphatase 1[2]
PP2A[4]
Ceramide-activated protein phosphatase (CAPP)[4]
Apoptosis[1]
Mitochondrial respiratory chain complex III[1]

Cellular Effect
Cell Line Type Value Description References
FL5.12 IC50
33 μM
Compound: 9
Cytotoxicity against mouse FL5.12A cells after 48 hrs by DAPI staining-based flow cytometric analysis
Cytotoxicity against mouse FL5.12A cells after 48 hrs by DAPI staining-based flow cytometric analysis
[PMID: 27475534]
HCT-116 EC50
24.5 μM
Compound: 3, C2-ceramide
Cytotoxicity against HCT116 cells assessed as cell survival by SRB assay
Cytotoxicity against HCT116 cells assessed as cell survival by SRB assay
[PMID: 17561396]
HepG2 IC50
58 μM
Compound: 1a
Antiproliferative activity against human HepG2 cells after 24 hrs by Alamar blue assay
Antiproliferative activity against human HepG2 cells after 24 hrs by Alamar blue assay
[PMID: 25172146]
HL-60 IC50
26 μM
Compound: 1a
Antiproliferative activity against human HL60 cells after 24 hrs by Alamar blue assay
Antiproliferative activity against human HL60 cells after 24 hrs by Alamar blue assay
[PMID: 25172146]
HT-29 IC50
25.9 μM
Compound: C2-ceramide
Antiproliferative activity against human HT-29 cells measured after 72 hrs by sulforhodamine B assay
Antiproliferative activity against human HT-29 cells measured after 72 hrs by sulforhodamine B assay
[PMID: 33592537]
K562 EC50
35.1 μM
Compound: 3, C2-ceramide
Cytotoxicity against K562 cells assessed as cell survival by MTT assay
Cytotoxicity against K562 cells assessed as cell survival by MTT assay
[PMID: 17561396]
MCF7 IC50
45.41 μM
Compound: 1, C2 ceramide
Cytotoxicity against human MCF7 cells after 24 hrs by CellTiter-Blue assay
Cytotoxicity against human MCF7 cells after 24 hrs by CellTiter-Blue assay
[PMID: 19171486]
MDA-MB-231 IC50
35.37 μM
Compound: 1, C2 ceramide
Cytotoxicity against human MDA-MB-231 cells after 24 hrs by CellTiter-Blue assay
Cytotoxicity against human MDA-MB-231 cells after 24 hrs by CellTiter-Blue assay
[PMID: 19171486]
NCI-H358 EC50
19.6 μM
Compound: 3, C2-ceramide
Cytotoxicity against NCI-H358 cells assessed as cell survival by SRB assay
Cytotoxicity against NCI-H358 cells assessed as cell survival by SRB assay
[PMID: 17561396]
NHDF IC50
66.5 μM
Compound: 1, C2 ceramide
Cytotoxicity against NHDF after 24 hrs by CellTiter-Blue assay
Cytotoxicity against NHDF after 24 hrs by CellTiter-Blue assay
[PMID: 19171486]
PC-12 IC50
98 μM
Compound: 1a
Antiproliferative activity against rat PC12 cells after 24 hrs by Alamar blue assay
Antiproliferative activity against rat PC12 cells after 24 hrs by Alamar blue assay
[PMID: 25172146]
SK-BR-3 IC50
49.2 μM
Compound: 1, C2 ceramide
Cytotoxicity against human SKBR3 cells after 24 hrs by CellTiter-Blue assay
Cytotoxicity against human SKBR3 cells after 24 hrs by CellTiter-Blue assay
[PMID: 19171486]
SUP-T1 IC50
41.44 μM
Compound: 1, C2 ceramide
Cytotoxicity against human SupT1 cells after 24 hrs by CellTiter-Blue assay
Cytotoxicity against human SupT1 cells after 24 hrs by CellTiter-Blue assay
[PMID: 19171486]
In Vitro

C2 Ceramide (5 nM-200 μM; 24 hours; primary mouse osteoblasts) treatment (≤500 nM) promots osteoblast viability, whilst concentrations ≥2 μM significantly reduces osteoblast viability in a dose- and time-dependent manner[1].
C2 Ceramide increases cytoplasmic histone-associated DNA fragments by 5.7- and 11.2-fold at 50 μM and 100 μM C2 Ceramide concentrations respectively in osteoblasts. At these higher concentrations, C2 Ceramide is a potent inducer of apoptosis in osteoblasts[1].
C2 Ceramide up-regulates mRNA expression of angiogenic genes in human dental pulp cells (HDPCs) and increases the migration and capillary tube formation of endothelial cells, whereas PP1 small interfering RNA shows opposite effects. Human dental pulp cells (HDPCs) increases levels of bone morphogenetic protein 2, phosphorylation of Smad 1/5/8, and mRNA expression of runt-related transcription factor 2 and osterix[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: Primary mouse osteoblasts
Concentration: 5 nM-200 µM
Incubation Time: 24 hours
Result: Murine osteoblasts demonstrated a dose-dependent increase in their survival rate when exposed to low concentrations of 5-500 n M. Increasing concentrations of 20-200µM caused a dose-dependent decrease in mitochondrial succinate dehydrogenase activity and osteoblast survival.
In Vivo

The PP1 activator C2 Ceramide increases alkaline phosphatase activity, mineralizes nodule formation, and mRNA expression of dentin matrix protein 1 and dentin sialophosphoprotein. In contrast, knockdown by PP1 small interfering RNA inhibits odontoblastic differentiation[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Peso molecular

341.53

Fòrmula

C20H39NO3

No. CAS

3102-57-6

Appearance

Solid

Color

White to off-white

SMILES

O[C@H](/C=C/CCCCCCCCCCCCC)[C@H](CO)NC(C)=O

Envío

Room temperature in continental US; may vary elsewhere.

Almacenamiento

-20°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

Solvente y solubilidad
In Vitro: 

DMSO : 20 mg/mL (58.56 mM; Need ultrasonic and warming; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Ethanol : 17 mg/mL (49.78 mM; Need ultrasonic and warming)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.9280 mL 14.6400 mL 29.2800 mL
5 mM 0.5856 mL 2.9280 mL 5.8560 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Calculadora de molaridad

  • Calculadora de dilución

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
Pureza y Documentación

Purity: 99.85%

Referencias
  • [1]. P A Hill, et al. Ceramide-induced Cell Death/Survival in Murine Osteoblasts. J Endocrinol. 2010 Aug;206(2):225-33.  [Content Brief]

    [2]. Ji-Youn Kim, et al. Role of Protein Phosphatase 1 in Angiogenesis and Odontoblastic Differentiation of Human Dental Pulp Cells. J Endod. 2017 Mar;43(3):417-424.  [Content Brief]

    [3]. R T Dobrowsky, et al. Ceramide Stimulates a Cytosolic Protein Phosphatase. J Biol Chem. 1992 Mar 15;267(8):5048-51.  [Content Brief]

    [4]. R T Dobrowsky, et al. Ceramide Activates Heterotrimeric Protein Phosphatase 2A. J Biol Chem. 1993 Jul 25;268(21):15523-30.  [Content Brief]

    [5]. Maria Bernadete Riemma Pierre, et al. Influence of ceramide 2 on in vitro skin permeation and retention of 5-ALA and its ester derivatives, for Photodynamic Therapy. Brazilian Journal of Pharmaceutical Sciences. 2009, 45(1), 109-116.

    [6]. Wenyuan Zhu, et al. C2-ceramide induces cell death and protective autophagy in head and neck squamous cell carcinoma cells. Int J Mol Sci. 2014 Feb 21;15(2):3336-55.  [Content Brief]

  • [1]. P A Hill, et al. Ceramide-induced Cell Death/Survival in Murine Osteoblasts. J Endocrinol. 2010 Aug;206(2):225-33.

    [2]. Ji-Youn Kim, et al. Role of Protein Phosphatase 1 in Angiogenesis and Odontoblastic Differentiation of Human Dental Pulp Cells. J Endod. 2017 Mar;43(3):417-424.

    [3]. R T Dobrowsky, et al. Ceramide Stimulates a Cytosolic Protein Phosphatase. J Biol Chem. 1992 Mar 15;267(8):5048-51.

    [4]. R T Dobrowsky, et al. Ceramide Activates Heterotrimeric Protein Phosphatase 2A. J Biol Chem. 1993 Jul 25;268(21):15523-30.

    [5]. Maria Bernadete Riemma Pierre, et al. Influence of ceramide 2 on in vitro skin permeation and retention of 5-ALA and its ester derivatives, for Photodynamic Therapy. Brazilian Journal of Pharmaceutical Sciences. 2009, 45(1), 109-116.

    [6]. Wenyuan Zhu, et al. C2-ceramide induces cell death and protective autophagy in head and neck squamous cell carcinoma cells. Int J Mol Sci. 2014 Feb 21;15(2):3336-55.

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
Ethanol / DMSO 1 mM 2.9280 mL 14.6400 mL 29.2800 mL 73.2000 mL
5 mM 0.5856 mL 2.9280 mL 5.8560 mL 14.6400 mL
10 mM 0.2928 mL 1.4640 mL 2.9280 mL 7.3200 mL
15 mM 0.1952 mL 0.9760 mL 1.9520 mL 4.8800 mL
20 mM 0.1464 mL 0.7320 mL 1.4640 mL 3.6600 mL
25 mM 0.1171 mL 0.5856 mL 1.1712 mL 2.9280 mL
30 mM 0.0976 mL 0.4880 mL 0.9760 mL 2.4400 mL
40 mM 0.0732 mL 0.3660 mL 0.7320 mL 1.8300 mL
DMSO 50 mM 0.0586 mL 0.2928 mL 0.5856 mL 1.4640 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

C2 Ceramide Related Classifications

  • Metabolic Enzyme/Protease Apoptosis Autophagy
  • Phosphatase Mitochondrial Metabolism Apoptosis Autophagy
Help & FAQs

Keywords:

C2 Ceramide3102-57-6Ceramide 2Ceramide2Ceramide-2PhosphataseMitochondrial MetabolismApoptosisAutophagySkinpenetrationlipidceramidesdentalPP1angiogenesisdifferentiationmitochondrialrespiratoryPP2ACAPPInhibitorinhibitorinhibit